Guardant Health Investor Presentation slide image

Guardant Health Investor Presentation

The mission of Guardant Health is to conquer cancer with data Expanding precision oncology to all stages of disease through easier access to cancer's underlying molecular information Market leading comprehensive liquid biopsy Therapy selection 6,000+ 50+ biopharma companies 80,000+ 94% tests ordered Revenue growth¹ oncologists GUARDANT 360 MN Recurrence monitoring LUNAR - 1 Early detection LUNAR - 2 1 YTD as of September 30, 2018 compared to nine-months ended 2017 3 GUARDANT
View entire presentation